Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Requirement of cannabinoid CB(1) receptors in cortical pyramidal neurons for appropriate development of corticothalamic and thalamocortical projections.

Wu CS, Zhu J, Wager-Miller J, Wang S, O'Leary D, Monory K, Lutz B, Mackie K, Lu HC.

Eur J Neurosci. 2010 Sep;32(5):693-706. doi: 10.1111/j.1460-9568.2010.07337.x. Epub 2010 Jul 28.

2.
3.

A forward genetic screen with a thalamocortical axon reporter mouse yields novel neurodevelopment mutants and a distinct emx2 mutant phenotype.

Dwyer ND, Manning DK, Moran JL, Mudbhary R, Fleming MS, Favero CB, Vock VM, O'Leary DD, Walsh CA, Beier DR.

Neural Dev. 2011 Jan 7;6:3. doi: 10.1186/1749-8104-6-3.

4.

Differential subcellular recruitment of monoacylglycerol lipase generates spatial specificity of 2-arachidonoyl glycerol signaling during axonal pathfinding.

Keimpema E, Barabas K, Morozov YM, Tortoriello G, Torii M, Cameron G, Yanagawa Y, Watanabe M, Mackie K, Harkany T.

J Neurosci. 2010 Oct 20;30(42):13992-4007. doi: 10.1523/JNEUROSCI.2126-10.2010.

5.

The role of L1 in axon pathfinding and fasciculation.

Wiencken-Barger AE, Mavity-Hudson J, Bartsch U, Schachner M, Casagrande VA.

Cereb Cortex. 2004 Feb;14(2):121-31.

PMID:
14704209
6.

Endocannabinoid signaling controls pyramidal cell specification and long-range axon patterning.

Mulder J, Aguado T, Keimpema E, Barabás K, Ballester Rosado CJ, Nguyen L, Monory K, Marsicano G, Di Marzo V, Hurd YL, Guillemot F, Mackie K, Lutz B, Guzmán M, Lu HC, Galve-Roperh I, Harkany T.

Proc Natl Acad Sci U S A. 2008 Jun 24;105(25):8760-5. doi: 10.1073/pnas.0803545105. Epub 2008 Jun 18.

7.

The endocannabinoid receptor, CB1, is required for normal axonal growth and fasciculation.

Watson S, Chambers D, Hobbs C, Doherty P, Graham A.

Mol Cell Neurosci. 2008 May;38(1):89-97. doi: 10.1016/j.mcn.2008.02.001. Epub 2008 Mar 10.

PMID:
18378465
8.

Thalamocortical pathfinding defects precede degeneration of the reticular thalamic nucleus in polysialic acid-deficient mice.

Schiff M, Röckle I, Burkhardt H, Weinhold B, Hildebrandt H.

J Neurosci. 2011 Jan 26;31(4):1302-12. doi: 10.1523/JNEUROSCI.5609-10.2011.

9.

Corticothalamic and thalamocortical pathfinding in the mouse: dependence on intermediate targets and guidance axis.

Deng J, Elberger AJ.

Anat Embryol (Berl). 2003 Oct;207(3):177-92. Epub 2003 Sep 18.

PMID:
14505053
10.

The early development of thalamocortical and corticothalamic projections.

Miller B, Chou L, Finlay BL.

J Comp Neurol. 1993 Sep 1;335(1):16-41.

PMID:
8408772
11.

Choreography of early thalamocortical development.

Molnár Z, Higashi S, López-Bendito G.

Cereb Cortex. 2003 Jun;13(6):661-9.

PMID:
12764042
12.

The type 1 cannabinoid receptor is highly expressed in embryonic cortical projection neurons and negatively regulates neurite growth in vitro.

Vitalis T, Lainé J, Simon A, Roland A, Leterrier C, Lenkei Z.

Eur J Neurosci. 2008 Nov;28(9):1705-18. doi: 10.1111/j.1460-9568.2008.06484.x.

PMID:
18973587
13.

Hardwiring the brain: endocannabinoids shape neuronal connectivity.

Berghuis P, Rajnicek AM, Morozov YM, Ross RA, Mulder J, Urbán GM, Monory K, Marsicano G, Matteoli M, Canty A, Irving AJ, Katona I, Yanagawa Y, Rakic P, Lutz B, Mackie K, Harkany T.

Science. 2007 May 25;316(5828):1212-6.

14.

Developmental Switch in Spike Timing-Dependent Plasticity and Cannabinoid-Dependent Reorganization of the Thalamocortical Projection in the Barrel Cortex.

Itami C, Huang JY, Yamasaki M, Watanabe M, Lu HC, Kimura F.

J Neurosci. 2016 Jun 29;36(26):7039-54. doi: 10.1523/JNEUROSCI.4280-15.2016.

15.

Transient expression of serotonin 5-HT4 receptors in the mouse developing thalamocortical projections.

Slaten ER, Hernandez MC, Albay R 3rd, Lavian R, Janusonis S.

Dev Neurobiol. 2010 Feb 15;70(3):165-81. doi: 10.1002/dneu.20775.

16.

Termination and initial branch formation of SNAP-25-deficient thalamocortical fibres in heterochronic organotypic co-cultures.

Blakey D, Wilson MC, Molnár Z.

Eur J Neurosci. 2012 May;35(10):1586-94. doi: 10.1111/j.1460-9568.2012.08120.x.

17.

Pathfinding of corticothalamic axons relies on a rendezvous with thalamic projections.

Deck M, Lokmane L, Chauvet S, Mailhes C, Keita M, Niquille M, Yoshida M, Yoshida Y, Lebrand C, Mann F, Grove EA, Garel S.

Neuron. 2013 Feb 6;77(3):472-84. doi: 10.1016/j.neuron.2012.11.031.

18.

Molecular reorganization of endocannabinoid signalling in Alzheimer's disease.

Mulder J, Zilberter M, Pasquaré SJ, Alpár A, Schulte G, Ferreira SG, Köfalvi A, Martín-Moreno AM, Keimpema E, Tanila H, Watanabe M, Mackie K, Hortobágyi T, de Ceballos ML, Harkany T.

Brain. 2011 Apr;134(Pt 4):1041-60. doi: 10.1093/brain/awr046.

19.

The expression and activity of β-catenin in the thalamus and its projections to the cerebral cortex in the mouse embryo.

Pratt T, Davey JW, Nowakowski TJ, Raasumaa C, Rawlik K, McBride D, Clinton M, Mason JO, Price DJ.

BMC Neurosci. 2012 Feb 23;13:20. doi: 10.1186/1471-2202-13-20.

20.

Expansion of the piriform cortex contributes to corticothalamic pathfinding defects in Gli3 conditional mutants.

Amaniti EM, Fu C, Lewis S, Saisana M, Magnani D, Mason JO, Theil T.

Cereb Cortex. 2015 Feb;25(2):460-71. doi: 10.1093/cercor/bht244. Epub 2013 Sep 7.

PMID:
24014668

Supplemental Content

Support Center